Ticker LaunchReverse merger · Completed · FSTX
F-star Therapeutics Limited
Reverse merger with Spring Bank Pharmaceuticals, Inc. (SBPH)
F-star Therapeutics Limited merged into Spring Bank Pharmaceuticals, Inc. (SBPH), a Nasdaq-listed pharmaceutical company, in a reverse merger that takes the private company public. The deal was announced on Jul 29, 2020 and closed on Nov 20, 2020. The combined company trades as F-star Therapeutics, Inc. (FSTX) on Nasdaq.
F-star Therapeutics is a clinical-stage immuno-oncology company developing tetravalent bispecific antibodies for cancer, built on a natural human IgG1 format. It became Nasdaq-listed through its share-exchange combination with Spring Bank Pharmaceuticals.
- Status
- Completed
- Private company
- F-star Therapeutics Limited
- Public company
- Spring Bank Pharmaceuticals, Inc. (SBPH)
- Public company business before
- Nasdaq-listed pharmaceutical company
- Announced
- Jul 29, 2020
- Closed
- Nov 20, 2020
- Combined company
- F-star Therapeutics, Inc. (FSTX)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Contingent value rights (CVR)
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Nov 20, 2020
- Closing press release
- All filings on EDGAR CIK 1566373
Other completed reverse mergers
- Metuchen Pharmaceuticals LLCinto Neurotrope, Inc. · Dec 2, 2020
- Eagle Lake Laboratories, Inc.into Sollensys Corp. · Nov 30, 2020
- Powertech Holdings Company Limitedinto Folkup Development Inc. · Nov 25, 2020
- MedAvail, Inc.into MYOS RENS Technology Inc. · Nov 18, 2020
- Medi-Scan, Inc.into HYB Holding Corp. · Nov 16, 2020
- West Of Hudson Group, Inc.into Tongji Healthcare Group, Inc. · Nov 12, 2020